Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary Analysis

IMPORTANCE: Debate continues about the value of event adjudication in clinical trials and whether independent centralized assessments improve reliability and validity of study results in masked randomized trials compared with local, investigator-assessed end points. OBJECTIVE: To assess the results...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:JAMA Netw Open
Päätekijät: Farrant, Mary, Easton, J. Donald, Adelman, Eric E., Cucchiara, Brett L., Barsan, William G., Tillman, Holly J., Elm, Jordan J., Kim, Anthony S., Lindblad, Anne S., Palesch, Yuko Y., Zhao, Wenle, Pauls, Keith, Walsh, Kyle B., Martí-Fàbregas, Joan, Bernstein, Richard A., Johnston, S. Claiborne
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Medical Association 2019
Aiheet:
Original Investigation
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6735409/
https://ncbi.nlm.nih.gov/pubmed/31490536
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamanetworkopen.2019.10769
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia